We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Olive Oil Compound Shows Potential as Treatment for Alzheimer's Disease

By LabMedica International staff writers
Posted on 12 Oct 2009
A component of extra virgin olive oil has been found to protect brain synapses from damage caused by the buildup of toxic soluble oligomers of amyloid-beta peptide (ADDLs) in patients with Alzheimer's disease (AD).

Most researchers now believe that soluble oligomers of amyloid-beta peptide, rather than insoluble fibrils, act as the primary neurotoxin in AD. More...
This has lead to a search for compounds capable of altering the assembly state of these oligomers and that may have potential for AD therapeutics.

One of these compounds is oleocanthal, which may be extracted from extra virgin olive oil. It is responsible for the slightly peppery "bite" of extra virgin olive oil, the cold-pressed result of the first pressing of the olives. This oil is only 1% acid and is considered the finest and fruitiest of the olive oils and is therefore the most expensive. Oleocanthal is a tyrosol ester, and its chemical structure is related to oleuropein that is also found in olive oil.

Oleocanthal has been found to have antiinflammatory and antioxidant properties. Similar to classical NSAIDs (nonsteroidal antiinflammatory drugs), it is a nonselective inhibitor of cyclooxygenase (COX). It has been suggested that long-term consumption of small quantities of oleocanthal from olive oil may be responsible in part for the low incidence of heart disease associated with a Mediterranean diet.

Investigators at Northwestern University (Evanston, IL, USA) studied the direct effect of oleocanthal on ADDL structure and on the binding of ADDLs to synapses.

They reported in the October 15, 2009, online edition of the journal Toxicology and Applied Pharmacology that treatment with oleocanthal increased the apparent size of ADDLs and rendered them more accessible to antibody binding. Treated ADDLs were found to be less able to interact with and bind to synapses of cultured hippocampal neurons. The hippocampus, a part of the brain intimately involved in learning and memory, is one of the first areas affected by AD.

"Binding of ADDLs to nerve cell synapses is thought to be a crucial first step in the initiation of Alzheimer's disease. Oleocanthal alters ADDL structure in a way that deters their binding to synapses," said senior author Dr. William L. Klein, professor of neurobiology and physiology at Northwestern University.

Related Links:

Northwestern University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.